The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications

Other users also viewed these articles

The clinical utility of faecal calprotectin in patients with differentiated and undifferentiated spondyloarthritis: Relevance and clinical implications Yasser Emad, Yasser Ragab, Nevin Hammam, Nashwa El-Shaarawy, Magdy Fawzi, Arwa Amer, Hesham El-Makhzangy, Ahmed Ismail, Ossama Ibrahim, Yosra Hassan, Ahmed Kamal, Johannes J. Rasker

10.1016/j.reumae.2020.10.005

Relationship Between Fecal Calprotectin, Anti-Saccharomyces cerevisiae Antibodies and Other Markers of Disease Activity in Patients With Spondyloarthritis María José Moreno Martínez, Manuel José Moreno Ramos, Luis Francisco Linares Ferrando

10.1016/j.reumae.2017.11.005

Recommendations for the Prescription of Physical Exercise for Patients With Spondyloarthritis Mariano Tomás Flórez García, Loreto Carmona, Raquel Almodóvar, César Fernández de las Peñas, Fernando García Pérez, M. Ángeles Pérez Manzanero, José Manuel García García, Lidón Soriano Segarra, José Fernando Jiménez Díaz, Nuria Mendoza Laiz, Eugenio de Miguel Mendieta, Juan Carlos Torre Alonso, Luis Francisco Linares Ferrando, Eduardo Collantes Estévez, Jesús Sanz Sanz, Pedro Zarco Montejo

10.1016/j.reumae.2018.11.004